Avidity Partners Management as of Dec. 31, 2021
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 97 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Abbvie (ABBV) | 5.7 | $269M | 2.0M | 135.40 | |
Zentalis Pharmaceuticals (ZNTL) | 4.8 | $228M | 2.7M | 84.06 | |
Arvinas Ord (ARVN) | 4.4 | $208M | 2.5M | 82.14 | |
Avantor (AVTR) | 4.3 | $202M | 4.8M | 42.14 | |
Astrazeneca Sponsored Adr (AZN) | 3.5 | $167M | 2.9M | 58.25 | |
Biohaven Pharmaceutical Holding | 3.3 | $157M | 1.1M | 137.81 | |
Baxter International (BAX) | 3.2 | $152M | 1.8M | 85.84 | |
Anthem (ELV) | 3.2 | $149M | 321k | 463.54 | |
Pfizer (PFE) | 2.6 | $123M | 2.1M | 59.05 | |
Mirati Therapeutics | 2.5 | $118M | 806k | 146.69 | |
Iveric Bio | 2.5 | $116M | 7.0M | 16.72 | |
United Therapeutics Corporation (UTHR) | 2.5 | $116M | 535k | 216.08 | |
Arena Pharmaceuticals Com New | 2.4 | $113M | 1.2M | 92.94 | |
Horizon Therapeutics Pub L SHS | 2.3 | $109M | 1.0M | 107.76 | |
Neurocrine Biosciences (NBIX) | 2.3 | $107M | 1.3M | 85.17 | |
Blueprint Medicines (BPMC) | 2.3 | $107M | 995k | 107.11 | |
Seagen | 2.2 | $106M | 685k | 154.60 | |
Syndax Pharmaceuticals (SNDX) | 2.2 | $106M | 4.8M | 21.89 | |
Eli Lilly & Co. (LLY) | 2.0 | $95M | 345k | 276.22 | |
Catalent (CTLT) | 1.9 | $89M | 695k | 128.03 | |
Natera (NTRA) | 1.9 | $88M | 940k | 93.39 | |
Hologic (HOLX) | 1.7 | $82M | 1.1M | 76.56 | |
Iovance Biotherapeutics (IOVA) | 1.5 | $72M | 3.8M | 19.09 | |
Sotera Health (SHC) | 1.5 | $70M | 3.0M | 23.55 | |
Nuvation Bio Com Cl A (NUVB) | 1.3 | $63M | 7.4M | 8.50 | |
Alnylam Pharmaceuticals (ALNY) | 1.3 | $63M | 370k | 169.58 | |
UnitedHealth (UNH) | 1.3 | $62M | 123k | 502.14 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $62M | 280k | 219.60 | |
Ideaya Biosciences (IDYA) | 1.3 | $60M | 2.6M | 23.64 | |
Ultragenyx Pharmaceutical (RARE) | 1.2 | $59M | 700k | 84.09 | |
Arrowhead Pharmaceuticals (ARWR) | 1.2 | $58M | 875k | 66.30 | |
Stevanato Group S P A Ord Shs (STVN) | 1.2 | $57M | 2.5M | 22.45 | |
Gritstone Oncology Ord (GRTS) | 1.2 | $56M | 4.4M | 12.86 | |
Kezar Life Sciences (KZR) | 1.1 | $54M | 3.2M | 16.72 | |
Adicet Bio (ACET) | 1.1 | $53M | 3.0M | 17.49 | |
Avidity Biosciences Ord (RNA) | 0.9 | $43M | 1.8M | 23.77 | |
Kymera Therapeutics (KYMR) | 0.9 | $43M | 670k | 63.49 | |
Immunocore Hldgs Ads (IMCR) | 0.9 | $42M | 1.2M | 34.24 | |
Caribou Biosciences (CRBU) | 0.9 | $40M | 2.7M | 15.09 | |
Insmed Com Par $.01 (INSM) | 0.8 | $40M | 1.5M | 27.24 | |
Ortho Clinical Diagnostics H Ord Shs | 0.8 | $38M | 1.8M | 21.39 | |
Phathom Pharmaceuticals (PHAT) | 0.8 | $37M | 1.9M | 19.67 | |
Essa Pharma Com New (EPIX) | 0.7 | $35M | 2.5M | 14.20 | |
AMN Healthcare Services (AMN) | 0.7 | $34M | 280k | 122.33 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.7 | $33M | 712k | 46.61 | |
Alphatec Hldgs Com New (ATEC) | 0.7 | $32M | 2.8M | 11.43 | |
Bellus Health Com New | 0.6 | $30M | 3.8M | 8.05 | |
Vir Biotechnology (VIR) | 0.6 | $29M | 700k | 41.87 | |
Axsome Therapeutics (AXSM) | 0.6 | $29M | 775k | 37.78 | |
Seaspine Holdings | 0.6 | $27M | 2.0M | 13.62 | |
Altimmune Com New (ALT) | 0.5 | $25M | 2.8M | 9.16 | |
Miragen Therapeutics (VRDN) | 0.5 | $25M | 1.3M | 19.77 | |
Global Blood Therapeutics In | 0.5 | $25M | 862k | 29.27 | |
Chemocentryx | 0.5 | $24M | 644k | 36.41 | |
Si-bone (SIBN) | 0.5 | $22M | 987k | 22.21 | |
Cyteir Therapeutics | 0.4 | $21M | 1.8M | 11.37 | |
Alpine Immune Sciences | 0.4 | $19M | 1.3M | 13.85 | |
Relmada Therapeutics (RLMD) | 0.3 | $17M | 732k | 22.53 | |
Scynexis Com New (SCYX) | 0.3 | $14M | 2.2M | 6.10 | |
Century Therapeutics (IPSC) | 0.3 | $14M | 852k | 15.86 | |
Phasebio Pharmaceuticals | 0.2 | $12M | 4.4M | 2.61 | |
Hyperfine Com Cl A (HYPR) | 0.2 | $11M | 1.5M | 7.25 | |
Sentinelone Cl A (S) | 0.2 | $11M | 208k | 50.49 | |
Graphite Bio | 0.2 | $8.8M | 710k | 12.43 | |
Field Trip Health Ord | 0.2 | $7.9M | 3.2M | 2.46 | |
Tango Therapeutics (TNGX) | 0.2 | $7.7M | 705k | 10.94 | |
ACADIA Pharmaceuticals (ACAD) | 0.1 | $7.0M | 300k | 23.34 | |
Instil Bio | 0.1 | $7.0M | 408k | 17.11 | |
Talaris Therapeutics | 0.1 | $7.0M | 455k | 15.29 | |
Definitive Healthcare Corp Class A Com (DH) | 0.1 | $6.8M | 250k | 27.33 | |
Eqrx | 0.1 | $6.8M | 1.0M | 6.82 | |
Caremax Com Cl A | 0.1 | $6.4M | 827k | 7.68 | |
Compass Therapeutics (CMPX) | 0.1 | $6.3M | 2.0M | 3.17 | |
Monte Rosa Therapeutics (GLUE) | 0.1 | $6.1M | 300k | 20.42 | |
Werewolf Therapeutics (HOWL) | 0.1 | $5.8M | 485k | 11.91 | |
Medicus Sciences Acquisition Cl A Shs | 0.1 | $5.0M | 520k | 9.69 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $5.0M | 500k | 9.92 | |
Dynamics Special Purpose Cor Class A Com | 0.1 | $4.9M | 500k | 9.86 | |
Science 37 Holdings | 0.1 | $4.9M | 394k | 12.47 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $4.9M | 500k | 9.80 | |
Panacea Acquisition Corp Ii Cl A Shs | 0.1 | $4.9M | 500k | 9.70 | |
Entrada Therapeutics (TRDA) | 0.1 | $4.4M | 255k | 17.12 | |
Sema4 Holdings Corp Com Cl A | 0.1 | $4.2M | 950k | 4.46 | |
Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.0M | 400k | 10.08 | |
Helix Acquisition Corp Com Cl A | 0.1 | $4.0M | 400k | 9.89 | |
Somalogic Class A Com | 0.1 | $3.8M | 330k | 11.64 | |
Merus N V (MRUS) | 0.1 | $3.3M | 103k | 31.80 | |
Oncosec Medical Incorporated | 0.1 | $2.8M | 2.9M | 0.96 | |
Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.93 | |
Social Cap Suvretta Hld Crpi Class A Ord Shs | 0.0 | $2.0M | 200k | 9.90 | |
Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.89 | |
Social Cap Suvretta Hlds Cp Class A Ord Shs | 0.0 | $2.0M | 200k | 9.82 | |
Shattuck Labs (STTK) | 0.0 | $1.4M | 165k | 8.51 | |
ZIOPHARM Oncology | 0.0 | $643k | 590k | 1.09 | |
Somalogic *w Exp 08/31/202 | 0.0 | $220k | 66k | 3.33 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $189k | 100k | 1.89 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $42k | 58k | 0.73 |